<https://rdf.molmedb.upol.cz/reference/ref4623> <http://purl.org/dc/terms/subject> <https://identifiers.org/molmedb/MM497584>,
		<https://identifiers.org/molmedb/MM497583>,
		<https://identifiers.org/molmedb/MM497584.1>;
	<http://purl.org/ontology/bibo/pmid> "22572583"^^<http://www.w3.org/2001/XMLSchema#string>;
	<http://purl.org/ontology/bibo/doi> "10.1016/j.bmcl.2012.04.060"^^<http://www.w3.org/2001/XMLSchema#string>;
	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/dc/terms/BibliographicResource>;
	<http://purl.org/dc/terms/subject> <https://rdf.molmedb.upol.cz/interaction/method91>,
		<https://rdf.molmedb.upol.cz/interaction/membrane64>;
	<http://purl.org/dc/terms/bibliographicCitation> "Monenschein H, Horne DB, Bartberger MD, Hitchcock SA, Nguyen TT, Patel VF, Pennington LD, Zhong W.: Structure guided P1' modifications of HEA derived β-secretase inhibitors for the treatment of Alzheimer's disease. Bioorg Med Chem Lett, Volume 22 (11), 2012"^^<http://www.w3.org/2001/XMLSchema#string>;
	<http://purl.org/dc/terms/subject> <https://identifiers.org/molmedb/MM497583.2>,
		<https://identifiers.org/molmedb/MM497583.1> .
<https://rdf.molmedb.upol.cz/interaction/int1031515> <http://www.w3.org/ns/prov#hadPrimarySource> <https://rdf.molmedb.upol.cz/reference/ref4623> .
<https://rdf.molmedb.upol.cz/interaction/int1031516> <http://www.w3.org/ns/prov#hadPrimarySource> <https://rdf.molmedb.upol.cz/reference/ref4623> .
<https://rdf.molmedb.upol.cz/interaction/int1031517> <http://www.w3.org/ns/prov#hadPrimarySource> <https://rdf.molmedb.upol.cz/reference/ref4623> .